1.0Public Citizenhttps://www.citizen.orgDiane Krauthamerhttps://www.citizen.org/author/dkrauthamer/Petition to the FDA to Require a Warning About a Dangerous Drug Interaction Between Clopidogrel (Plavix) and Repaglinide (Prandin) in the Label for Both Drugs - Public Citizenrich600338<blockquote class="wp-embedded-content" data-secret="Ek7m0MBBB9"><a href="https://www.citizen.org/article/petition-to-the-fda-to-require-a-warning-about-a-dangerous-drug-interaction-between-clopidogrel-plavix-and-repaglinide-prandin-in-the-label-for-both-drugs/">Petition to the FDA to Require a Warning About a Dangerous Drug Interaction Between Clopidogrel (Plavix) and Repaglinide (Prandin) in the Label for Both Drugs</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.citizen.org/article/petition-to-the-fda-to-require-a-warning-about-a-dangerous-drug-interaction-between-clopidogrel-plavix-and-repaglinide-prandin-in-the-label-for-both-drugs/embed/#?secret=Ek7m0MBBB9" width="600" height="338" title="“Petition to the FDA to Require a Warning About a Dangerous Drug Interaction Between Clopidogrel (Plavix) and Repaglinide (Prandin) in the Label for Both Drugs” — Public Citizen" data-secret="Ek7m0MBBB9" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
Public Citizen petitions the Food and Drug Administration (FDA) to require that the labels of the anti-clotting drug clopidogrel (Plavix) and the diabetes drug repaglinide (Prandin) warn doctors and patients that taking the drugs together can cause dangerously low blood sugar levels. The petition also asks that the drugs’ labels include a statement that the two drugs should never be taken together under any circumstances.https://www.citizen.org/wp-content/uploads/public_citizen_shared_link.jpg1200628